As recently as the onset of COVID-19 four years ago, you probably didnt know what a glucagon-like peptide 1 agonist, or GLP-1 drug, was
doi: 10.1038/s41514-022-00084-z
Do not freeze reconstituted solution or expose to repeated temperature cycling
Retatrutide is still in clinical trials, so its full safety profile is not yet known
Therefore, retatrutide is not indicated for individuals under 18 years of age
Further studies are needed to investigate this hypothesis, but we suspect recent changes in medication prescribing practices and medication prices will result in large datasets allowing scientists to investigate these potential relationships. Christine Rode Schwarz, PhD, of the Steno Diabetes Center in Copenhagen, and her co-authors pointed to this case in a commentary titled, Mechanism and Context: Making Sense of Adverse Events With GLP-1-based Therapy , also published in JCEM Case Reports later that year